Theravance Biopharma shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Theravance Biopharma by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $508k | 63k | 8.06 |
2024-06-30 | $654k | 77k | 8.48 |
2024-03-31 | $827k | 92k | 8.97 |
2023-12-31 | $1.1M | 97k | 11.24 |
2023-09-30 | $890k | 103k | 8.63 |
2023-06-30 | $1.1M | 106k | 10.35 |
2023-03-31 | $939k | 87k | 10.86 |
2022-12-31 | $935k | 83k | 11.22 |
2022-09-30 | $818k | 81k | 10.15 |
2022-06-30 | $678k | 75k | 9.05 |
2022-03-31 | $604k | 63k | 9.56 |
2021-12-31 | $691k | 63k | 11.05 |
2021-09-30 | $450k | 61k | 7.40 |
2021-06-30 | $848k | 58k | 14.52 |
2021-03-31 | $1.3M | 62k | 20.42 |
2020-12-31 | $1.2M | 65k | 17.77 |
2020-09-30 | $918k | 62k | 14.79 |
2020-06-30 | $1.5M | 71k | 20.99 |
2020-03-31 | $1.4M | 62k | 23.11 |
2019-12-31 | $1.5M | 58k | 25.88 |
2019-09-30 | $1.1M | 57k | 19.48 |
2019-06-30 | $932k | 57k | 16.33 |
2019-03-31 | $1.3M | 55k | 22.66 |
2018-12-31 | $1.4M | 56k | 25.58 |
2018-09-30 | $1.2M | 37k | 32.68 |
2018-06-30 | $902k | 40k | 22.67 |
2018-03-31 | $922k | 38k | 24.25 |
2017-12-31 | $1.1M | 39k | 27.89 |
2017-09-30 | $1.6M | 46k | 34.24 |
2017-06-30 | $1.8M | 46k | 39.83 |
2017-03-31 | $1.6M | 44k | 36.82 |
2016-12-31 | $1.3M | 41k | 31.87 |
2016-09-30 | $1.3M | 37k | 36.23 |
2016-06-30 | $772k | 34k | 22.69 |
2016-03-31 | $785k | 42k | 18.81 |
2015-12-31 | $566k | 35k | 16.38 |
2015-09-30 | $370k | 34k | 11.00 |
2015-06-30 | $414k | 32k | 13.03 |
2015-03-31 | $399k | 23k | 17.37 |
2014-12-31 | $301k | 20k | 14.90 |
2014-09-30 | $449k | 20k | 23.06 |
2014-06-30 | $666k | 21k | 31.90 |